Esperion Therapeutics, Inc.·4

Jan 29, 5:01 PM ET

Hall Ashley 4

4 · Esperion Therapeutics, Inc. · Filed Jan 29, 2021

Insider Transaction Report

Form 4
Period: 2021-01-28
Hall Ashley
Chief Development Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-01-28+31,00031,000 total
    Exercise: $32.12Exp: 2031-01-28Common Stock (31,000 underlying)
  • Award

    Common Stock

    2021-01-28+7,00022,500 total
Footnotes (1)
  • [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be May 15, 2021.

Documents

1 file
  • 4
    wf-form4_161195765095069.xmlPrimary

    FORM 4